| Literature DB >> 30811989 |
Riem Gawish1, Tanja Bulat1, Mario Biaggio1, Caroline Lassnig2, Zsuzsanna Bago-Horvath3, Sabine Macho-Maschler2, Andrea Poelzl1, Natalija Simonović1, Michaela Prchal-Murphy4, Rita Rom1, Lena Amenitsch1, Luca Ferrarese1, Juliana Kornhoff1, Therese Lederer1, Jasmin Svinka5, Robert Eferl5, Markus Bosmann6, Ulrich Kalinke7, Dagmar Stoiber8, Veronika Sexl4, Astrid Krmpotić9, Stipan Jonjić9, Mathias Müller10, Birgit Strobl11.
Abstract
Cytomegalovirus (CMV) has a high prevalence worldwide, is often fatal for immunocompromised patients, and causes bone marrow suppression. Deficiency of signal transducer and activator of transcription 1 (STAT1) results in severely impaired antiviral immunity. We have used cell-type restricted deletion of Stat1 to determine the importance of myeloid cell activity for the defense against murine CMV (MCMV). We show that myeloid STAT1 limits MCMV burden and infection-associated pathology in the spleen but does not affect ultimate clearance of infection. Unexpectedly, we found an essential role of myeloid STAT1 in the induction of extramedullary hematopoiesis (EMH). The EMH-promoting function of STAT1 was not restricted to MCMV infection but was also observed during CpG oligodeoxynucleotide-induced sterile inflammation. Collectively, we provide genetic evidence that signaling through STAT1 in myeloid cells is required to restrict MCMV at early time points post-infection and to induce compensatory hematopoiesis in the spleen.Entities:
Keywords: Herpesviridae; IFN-I receptor; IFN-II receptor; IL-27 receptor; TLR9 agonist; monocytes; signal transducer and activator of transcription
Year: 2019 PMID: 30811989 PMCID: PMC6447072 DOI: 10.1016/j.celrep.2019.02.017
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423